
Global top companies based on biotech prescription drug revenue in 2019 and 2026
Merck & Co. generated some 20 billion U.S. dollars in biotechnology drug sales in 2019 and is predicted to generate more than 37 billion U.S. dollars in biotech prescription drug revenues worldwide in 2026. This statistic depicts the biotech prescription drug revenues of the top ten companies globally in 2019, and a 2026 prediction.